ArticleActa pharmaceutica Sinica. B2022

Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth

Fanxiang Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.